Nazif-Munoz José Ignacio, Ouimet Marie Claude
Université de Sherbrooke, Longueuil, Québec, Canada.
Traffic Inj Prev. 2025 Aug 19:1-9. doi: 10.1080/15389588.2025.2537145.
This study examines the impact of non-medical cannabis laws (NMCLs) on road safety outcomes, specifically focusing on drug- and alcohol-related traffic crashes. Using cannabis sales data as a proxy for consumption trends, the study aims to assess how changes in cannabis availability may influence road safety outcomes, particularly exploring the potential for drugs and alcohol to have distinct yet related influences on impaired driving.
An interrupted time-series design was used to assess the impact of NMCLs on daily drug- and alcohol-related traffic crashes, including fatalities and severe injuries (KSI). The analysis covered five cities in the province of Québec-Montréal, Québec, Laval, Longueuil, and Sherbrooke-using data from January 1, 2015; to December 31, 2022. The dependent variables included KSI, drug-related crashes, and alcohol-related crashes, while the independent variables were daily cannabis legal sales (kg) and total legal and estimated illegal cannabis sales. Control variables accounted for temperature, time trends, and the COVID-19 non-pharmaceutical interventions' index for the province of Québec (QCnPI-Index). To estimate effects, we applied Generalized Linear Models using Negative binomial regression, followed by a random-effects meta-analysis to assess overall effects across cities.
Higher total cannabis sales were significantly associated with a 12% increase in drug-related crashes (IRR: 1.12; 95% CI: 1.01-1.27) and a 12% rise in alcohol-related crashes (IRR: 1.12; 95% CI: 1.06-1.18) across all cities combined. In Montréal, cannabis sales were linked to an 87% increase in drug-related crashes (IRR: 1.87; 95% CI: 1.54-2.28) and a 93% increase in alcohol-related crashes (IRR: 1.93; 95% CI: 1.58-2.36). In Longueuil, drug-related crashes rose by 76% (IRR: 1.76; 95% CI: 1.02-3.02) and alcohol-related crashes by 43% (IRR: 1.43; 95% CI: 1.08-1.92). Québec City only showed a 44% increase in alcohol-related crashes (IRR: 1.44; 95% CI: 1.28-1.64). No significant associations were found in Laval or Sherbrooke.
The findings suggest that increased cannabis availability, as measured by cannabis sales, is associated with higher rates of both drug- and alcohol-related crashes, particularly in Montréal and Longueuil. These results support the hypothesis that changes in cannabis availability may influence two distinct impaired driving patterns, highlighting the need for region-specific road safety interventions.
本研究考察非医用大麻法律(NMCLs)对道路安全结果的影响,特别关注与毒品和酒精相关的交通事故。该研究以大麻销售数据作为消费趋势的代理指标,旨在评估大麻可获得性的变化如何影响道路安全结果,尤其探讨毒品和酒精对驾驶能力受损可能产生的不同但相关的影响。
采用中断时间序列设计,评估非医用大麻法律对每日与毒品和酒精相关的交通事故的影响,包括死亡和重伤(KSI)。分析涵盖魁北克省的五个城市——蒙特利尔、魁北克市、拉瓦尔、隆格伊和舍布鲁克——使用2015年1月1日至2022年12月31日的数据。因变量包括KSI、与毒品相关的事故和与酒精相关的事故,自变量是每日合法大麻销售量(千克)以及合法和估计的非法大麻销售总量。控制变量包括温度、时间趋势以及魁北克省的新冠疫情非药物干预指数(QCnPI-Index)。为估计影响,我们应用广义线性模型进行负二项回归,随后进行随机效应荟萃分析以评估各城市的总体影响。
在所有城市中,大麻销售总量的增加与与毒品相关的事故显著增加12%(发病率比值比:1.12;95%置信区间:1.01 - 1.27)以及与酒精相关的事故增加12%(发病率比值比:1.12;95%置信区间:1.06 - 1.18)相关。在蒙特利尔,大麻销售与与毒品相关的事故增加87%(发病率比值比:1.87;95%置信区间:1.54 - 2.28)以及与酒精相关的事故增加93%(发病率比值比:1.93;95%置信区间:1.58 - 2.36)有关。在隆格伊,与毒品相关的事故增加了76%(发病率比值比:1.76;95%置信区间:1.02 - 3.02),与酒精相关的事故增加了43%(发病率比值比:1.43;95%置信区间:1.08 - 1.92)。魁北克市仅显示与酒精相关的事故增加了44%(发病率比值比:1.44;95%置信区间:1.28 - 1.64)。在拉瓦尔或舍布鲁克未发现显著关联。
研究结果表明,以大麻销售衡量的大麻可获得性增加与毒品和酒精相关事故的发生率升高有关,尤其是在蒙特利尔和隆格伊。这些结果支持了大麻可获得性的变化可能影响两种不同驾驶能力受损模式的假设,凸显了针对特定地区的道路安全干预措施的必要性。